CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

pf614

Small moleculeexperimental

Clinical trial activity

7 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Nov 1, 2016 (NCT02454712)

Timeline

2010s

  1. Jan 1, 2016

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2023

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • pf614

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06602271Phase 3Mar 31, 2025Ensysce Biosciences
NCT06500793Phase 1Nov 30, 2024Ensysce Biosciences, Quotient
NCT06629402Phase 2Oct 5, 2023Dr. Vince Clinical Research, Ensysce Biosciences
NCT05571345Phase 1Oct 5, 2022Dr. Vince Clinical Research, Ensysce Biosciences
NCT05567354Phase 1Jun 10, 2022Ensysce Biosciences, OCT Clinical Trials
NCT05043766Phase 1Sep 8, 2021Ensysce Biosciences, Pharmaceutical Research Associates, Inc. (PRA)
NCT02454712Phase 1Nov 1, 2016Ensysce Biosciences, Pharmaceutical Research Associates, Inc. (PRA)
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Ensysce BiosciencesFor profit7732016
Dr. Vince Clinical ResearchFor profit2022022
Pharmaceutical Research Associates, Inc. (PRA)For profit2012016
OCT Clinical TrialsFor profit1012022
QuotientFor profit1012024
5 organizations
Page 1 / 1